TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

Barbara Burtness et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.